A critical methodology newsletter by a clinical-trial researcher that appraises oncology trial results, especially the CHALLENGE exercise trial and the role of informative censoring in survival analysis. It also covers new tools such as the BREAKING-ICE app for visualising censoring.
Website: https://www.drugdevletter.com
A physician-author's blog analysing biotech and oncology developments, including clinical trial data, drug mechanisms and the implications of AI for medicine. Posts include conflict-of-interest disclosures and give detailed scientific commentary on specific companies and drugs.
Sanare Lab Science publishes near-daily write-ups of individual studies on repurposed drugs, supplements like curcumin, and experimental cancer approaches. Each issue gives a key takeaway, plain-language explanation, evidence-strength assessment and a note on what it means for patients.
An oncologist shares lectures and commentary on interpreting cancer clinical trials, including trial design, statistics and conference results. Readers get a critical, clinician's view of how to appraise evidence behind oncology drugs and combinations.
A physician with metastatic prostate cancer shares his treatment history, PSA and testosterone data, and experience on transdermal estradiol patches after intolerance to standard androgen deprivation therapy. Readers get a detailed patient-side account of alternative hormone therapy and the evidence behind it.
One short email a week with hand-picked newsletters from the index. Free, no spam, unsubscribe anytime.
